- Experian’s overall organic revenue increased by 8%, surpassing the estimated 6.26% growth.
- In North America, organic revenue grew by 9%, exceeding the estimate of 6.85%.
- Latin America’s organic revenue rose by 5%, which was below the 6.78% estimate.
- Organic revenue in the UK & Ireland saw a growth of 1%, missing the 2.45% estimate.
- The EMEA/Asia Pacific region reported a 7% organic revenue increase, slightly under the 8.14% estimate.
- B2B organic revenue matched the overall growth of 8%, beating the 5.87% estimate.
- Consumer Services had a 6% organic revenue growth.
- Analyst recommendations include 17 buys, 3 holds, and 2 sells.
A look at Experian PLC Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Experian PLC, a company specializing in credit and marketing services, has received a mixed outlook based on the Smartkarma Smart Scores. With a higher score in growth and momentum, Experian PLC seems poised for potential future expansion and positive market momentum. This suggests that the company may be well-positioned for long-term growth and prosperity in its industry.
However, Experian PLC‘s scores in value, dividend, and resilience are slightly lower, indicating areas where the company may need to focus on improvement. Despite this, Experian PLC remains a key player in managing databases for credit services and minimizing fraud and credit risk. With its offerings of specialist analytical solutions and consumer credit reports, Experian PLC continues to play a crucial role in the financial sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
